Monetta Financial Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Hold
13,300
1.44% 16
2025
Q4
$1.63M Buy
13,300
+3,300
+33% +$401K 1.17% 19
2025
Q3
$1.11M Hold
10,000
0.78% 39
2025
Q2
$1.11M Hold
10,000
0.81% 39
2025
Q1
$1.12M Hold
10,000
0.99% 25
2024
Q4
$924K Hold
10,000
0.74% 37
2024
Q3
$838K Buy
+10,000
New +$763K 0.71% 45
2024
Q1
Sell
-10,500
Closed -$851K 53
2023
Q4
$851K Buy
+10,500
New +$817K 0.81% 38
2022
Q1
Sell
-11,000
Closed -$799K 60
2021
Q4
$799K Buy
+11,000
New +$758K 0.62% 35
2016
Q1
Sell
-5,000
Closed -$506K 82
2015
Q4
$506K Hold
5,000
0.3% 81
2015
Q3
$491K Buy
+5,000
New +$555K 0.3% 73
2015
Q1
Sell
-10,000
Closed -$943K 97
2014
Q4
$943K Hold
10,000
0.49% 49
2014
Q3
$1.06M Buy
+10,000
New +$979K 0.56% 48

Other funds holding GILD

Monetta Financial Services's GILD Position: Q1 2026 in Review

Monetta Financial Services held its Gilead Sciences (GILD) position steady in Q1 2026 at 13,300 shares worth $1.85M. The position accounts for 1.44% of the portfolio, ranked #16.

Monetta Financial Services first reported a position in GILD in Q3 2014 and has held it in 13 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Monetta Financial Services held 13,300 shares of Gilead Sciences worth $1.85M as of Q1 2026.
  • Monetta Financial Services left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 1.44% of Monetta Financial Services's portfolio in Q1 2026, its #16 holding.
  • Monetta Financial Services first reported a position in Gilead Sciences in Q3 2014 and has held it in 13 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Monetta Financial Services's 13F filing for Q1 2026, filed 13 May 2026.